カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のベクターベースRNAi市場予測2023-2029：siRNA設計、siRNAベクター、カスタムsiRNA構築

【英語タイトル】Vector-Based RNAi Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8740）・商品コード：MMG23LY8740
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：76
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のベクターベースRNAi市場規模と予測を収録しています。・世界のベクターベースRNAi市場：売上、2018年-2023年、2024年-2029年
・世界のベクターベースRNAi市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のベクターベースRNAi市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「siRNA設計」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ベクターベースRNAiのグローバル主要企業は、Merck & Co.、 Phio Pharmaceutical、 Quark Pharmaceuticals、 Thermo Fisher Scientific、 Silence Therapeutics、 Qiagen NV、 Ionis Pharmaceutical、 Dicerna Pharmaceuticals、 Arrowhead Pharmaceuticals、 Arcturus Therapeutics、 Alnylam Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ベクターベースRNAiのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のベクターベースRNAi市場：タイプ別、2018年-2023年、2024年-2029年
世界のベクターベースRNAi市場：タイプ別市場シェア、2022年
・siRNA設計、siRNAベクター、カスタムsiRNA構築

世界のベクターベースRNAi市場：用途別、2018年-2023年、2024年-2029年
世界のベクターベースRNAi市場：用途別市場シェア、2022年
・病院、専門クリニック

世界のベクターベースRNAi市場：地域・国別、2018年-2023年、2024年-2029年
世界のベクターベースRNAi市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるベクターベースRNAiのグローバル売上、2018年-2023年
・主要企業におけるベクターベースRNAiのグローバル売上シェア、2022年
・主要企業におけるベクターベースRNAiのグローバル販売量、2018年-2023年
・主要企業におけるベクターベースRNAiのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck & Co.、 Phio Pharmaceutical、 Quark Pharmaceuticals、 Thermo Fisher Scientific、 Silence Therapeutics、 Qiagen NV、 Ionis Pharmaceutical、 Dicerna Pharmaceuticals、 Arrowhead Pharmaceuticals、 Arcturus Therapeutics、 Alnylam Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
ベクターベースRNAi市場の定義
市場セグメント
世界のベクターベースRNAi市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のベクターベースRNAi市場規模
世界のベクターベースRNAi市場規模：2022年 VS 2029年
世界のベクターベースRNAi市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのベクターベースRNAiの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のベクターベースRNAi製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：siRNA設計、siRNAベクター、カスタムsiRNA構築
ベクターベースRNAiのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門クリニック
ベクターベースRNAiの用途別グローバル売上・予測

・地域別市場分析
地域別ベクターベースRNAi市場規模 2022年と2029年
地域別ベクターベースRNAi売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck & Co.、 Phio Pharmaceutical、 Quark Pharmaceuticals、 Thermo Fisher Scientific、 Silence Therapeutics、 Qiagen NV、 Ionis Pharmaceutical、 Dicerna Pharmaceuticals、 Arrowhead Pharmaceuticals、 Arcturus Therapeutics、 Alnylam Pharmaceuticals
...

Vector-based RNAi (RNA interference) offers a system of treatment and disease management to decrease the inhibition of gene translation or expression, as well as it neutralizes the targeted mRNA molecules. Vector-based RNAi plays very important in cancer treatment,cancer is the top second cause of death across the globe. As well as a new development in vector-based RNAi such as small interfering RNAs (siRNA) and microRNAs (miRNA) can escalate the vector-based RNAi market growth. The challenging situation of FDA approval affecting on a number of new drugs launch, for instance, 2015 (41 drugs), while in 2016 (19 drugs) which are very less as compared with the previous year.
This report aims to provide a comprehensive presentation of the global market for Vector-Based RNAi, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vector-Based RNAi. This report contains market size and forecasts of Vector-Based RNAi in global, including the following market information:
Global Vector-Based RNAi Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Vector-Based RNAi Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Vector-Based RNAi companies in 2022 (%)
The global Vector-Based RNAi market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
siRNA Design Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Vector-Based RNAi include Merck & Co., Phio Pharmaceutical, Quark Pharmaceuticals, Thermo Fisher Scientific, Silence Therapeutics, Qiagen NV, Ionis Pharmaceutical, Dicerna Pharmaceuticals and Arrowhead Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vector-Based RNAi manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vector-Based RNAi Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vector-Based RNAi Market Segment Percentages, by Type, 2022 (%)
siRNA Design
siRNA Vectors
Custom siRNA Construction
Global Vector-Based RNAi Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vector-Based RNAi Market Segment Percentages, by Application, 2022 (%)
Hospitals
Speciality Clinics
Global Vector-Based RNAi Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Vector-Based RNAi Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vector-Based RNAi revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Vector-Based RNAi revenues share in global market, 2022 (%)
Key companies Vector-Based RNAi sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Vector-Based RNAi sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.
Phio Pharmaceutical
Quark Pharmaceuticals
Thermo Fisher Scientific
Silence Therapeutics
Qiagen NV
Ionis Pharmaceutical
Dicerna Pharmaceuticals
Arrowhead Pharmaceuticals
Arcturus Therapeutics
Alnylam Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vector-Based RNAi, market overview.
Chapter 2: Global Vector-Based RNAi market size in revenue and volume.
Chapter 3: Detailed analysis of Vector-Based RNAi manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vector-Based RNAi in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vector-Based RNAi capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Vector-Based RNAi Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vector-Based RNAi Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vector-Based RNAi Overall Market Size
2.1 Global Vector-Based RNAi Market Size: 2022 VS 2029
2.2 Global Vector-Based RNAi Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Vector-Based RNAi Sales: 2018-2029
3 Company Landscape
3.1 Top Vector-Based RNAi Players in Global Market
3.2 Top Global Vector-Based RNAi Companies Ranked by Revenue
3.3 Global Vector-Based RNAi Revenue by Companies
3.4 Global Vector-Based RNAi Sales by Companies
3.5 Global Vector-Based RNAi Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vector-Based RNAi Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vector-Based RNAi Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vector-Based RNAi Players in Global Market
3.8.1 List of Global Tier 1 Vector-Based RNAi Companies
3.8.2 List of Global Tier 2 and Tier 3 Vector-Based RNAi Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Vector-Based RNAi Market Size Markets, 2022 & 2029
4.1.2 siRNA Design
4.1.3 siRNA Vectors
4.1.4 Custom siRNA Construction
4.2 By Type – Global Vector-Based RNAi Revenue & Forecasts
4.2.1 By Type – Global Vector-Based RNAi Revenue, 2018-2023
4.2.2 By Type – Global Vector-Based RNAi Revenue, 2024-2029
4.2.3 By Type – Global Vector-Based RNAi Revenue Market Share, 2018-2029
4.3 By Type – Global Vector-Based RNAi Sales & Forecasts
4.3.1 By Type – Global Vector-Based RNAi Sales, 2018-2023
4.3.2 By Type – Global Vector-Based RNAi Sales, 2024-2029
4.3.3 By Type – Global Vector-Based RNAi Sales Market Share, 2018-2029
4.4 By Type – Global Vector-Based RNAi Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Vector-Based RNAi Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Speciality Clinics
5.2 By Application – Global Vector-Based RNAi Revenue & Forecasts
5.2.1 By Application – Global Vector-Based RNAi Revenue, 2018-2023
5.2.2 By Application – Global Vector-Based RNAi Revenue, 2024-2029
5.2.3 By Application – Global Vector-Based RNAi Revenue Market Share, 2018-2029
5.3 By Application – Global Vector-Based RNAi Sales & Forecasts
5.3.1 By Application – Global Vector-Based RNAi Sales, 2018-2023
5.3.2 By Application – Global Vector-Based RNAi Sales, 2024-2029
5.3.3 By Application – Global Vector-Based RNAi Sales Market Share, 2018-2029
5.4 By Application – Global Vector-Based RNAi Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Vector-Based RNAi Market Size, 2022 & 2029
6.2 By Region – Global Vector-Based RNAi Revenue & Forecasts
6.2.1 By Region – Global Vector-Based RNAi Revenue, 2018-2023
6.2.2 By Region – Global Vector-Based RNAi Revenue, 2024-2029
6.2.3 By Region – Global Vector-Based RNAi Revenue Market Share, 2018-2029
6.3 By Region – Global Vector-Based RNAi Sales & Forecasts
6.3.1 By Region – Global Vector-Based RNAi Sales, 2018-2023
6.3.2 By Region – Global Vector-Based RNAi Sales, 2024-2029
6.3.3 By Region – Global Vector-Based RNAi Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Vector-Based RNAi Revenue, 2018-2029
6.4.2 By Country – North America Vector-Based RNAi Sales, 2018-2029
6.4.3 US Vector-Based RNAi Market Size, 2018-2029
6.4.4 Canada Vector-Based RNAi Market Size, 2018-2029
6.4.5 Mexico Vector-Based RNAi Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Vector-Based RNAi Revenue, 2018-2029
6.5.2 By Country – Europe Vector-Based RNAi Sales, 2018-2029
6.5.3 Germany Vector-Based RNAi Market Size, 2018-2029
6.5.4 France Vector-Based RNAi Market Size, 2018-2029
6.5.5 U.K. Vector-Based RNAi Market Size, 2018-2029
6.5.6 Italy Vector-Based RNAi Market Size, 2018-2029
6.5.7 Russia Vector-Based RNAi Market Size, 2018-2029
6.5.8 Nordic Countries Vector-Based RNAi Market Size, 2018-2029
6.5.9 Benelux Vector-Based RNAi Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Vector-Based RNAi Revenue, 2018-2029
6.6.2 By Region – Asia Vector-Based RNAi Sales, 2018-2029
6.6.3 China Vector-Based RNAi Market Size, 2018-2029
6.6.4 Japan Vector-Based RNAi Market Size, 2018-2029
6.6.5 South Korea Vector-Based RNAi Market Size, 2018-2029
6.6.6 Southeast Asia Vector-Based RNAi Market Size, 2018-2029
6.6.7 India Vector-Based RNAi Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Vector-Based RNAi Revenue, 2018-2029
6.7.2 By Country – South America Vector-Based RNAi Sales, 2018-2029
6.7.3 Brazil Vector-Based RNAi Market Size, 2018-2029
6.7.4 Argentina Vector-Based RNAi Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Vector-Based RNAi Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Vector-Based RNAi Sales, 2018-2029
6.8.3 Turkey Vector-Based RNAi Market Size, 2018-2029
6.8.4 Israel Vector-Based RNAi Market Size, 2018-2029
6.8.5 Saudi Arabia Vector-Based RNAi Market Size, 2018-2029
6.8.6 UAE Vector-Based RNAi Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Company Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Vector-Based RNAi Major Product Offerings
7.1.4 Merck & Co. Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.1.5 Merck & Co. Key News & Latest Developments
7.2 Phio Pharmaceutical
7.2.1 Phio Pharmaceutical Company Summary
7.2.2 Phio Pharmaceutical Business Overview
7.2.3 Phio Pharmaceutical Vector-Based RNAi Major Product Offerings
7.2.4 Phio Pharmaceutical Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.2.5 Phio Pharmaceutical Key News & Latest Developments
7.3 Quark Pharmaceuticals
7.3.1 Quark Pharmaceuticals Company Summary
7.3.2 Quark Pharmaceuticals Business Overview
7.3.3 Quark Pharmaceuticals Vector-Based RNAi Major Product Offerings
7.3.4 Quark Pharmaceuticals Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.3.5 Quark Pharmaceuticals Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Vector-Based RNAi Major Product Offerings
7.4.4 Thermo Fisher Scientific Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 Silence Therapeutics
7.5.1 Silence Therapeutics Company Summary
7.5.2 Silence Therapeutics Business Overview
7.5.3 Silence Therapeutics Vector-Based RNAi Major Product Offerings
7.5.4 Silence Therapeutics Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.5.5 Silence Therapeutics Key News & Latest Developments
7.6 Qiagen NV
7.6.1 Qiagen NV Company Summary
7.6.2 Qiagen NV Business Overview
7.6.3 Qiagen NV Vector-Based RNAi Major Product Offerings
7.6.4 Qiagen NV Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.6.5 Qiagen NV Key News & Latest Developments
7.7 Ionis Pharmaceutical
7.7.1 Ionis Pharmaceutical Company Summary
7.7.2 Ionis Pharmaceutical Business Overview
7.7.3 Ionis Pharmaceutical Vector-Based RNAi Major Product Offerings
7.7.4 Ionis Pharmaceutical Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.7.5 Ionis Pharmaceutical Key News & Latest Developments
7.8 Dicerna Pharmaceuticals
7.8.1 Dicerna Pharmaceuticals Company Summary
7.8.2 Dicerna Pharmaceuticals Business Overview
7.8.3 Dicerna Pharmaceuticals Vector-Based RNAi Major Product Offerings
7.8.4 Dicerna Pharmaceuticals Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.8.5 Dicerna Pharmaceuticals Key News & Latest Developments
7.9 Arrowhead Pharmaceuticals
7.9.1 Arrowhead Pharmaceuticals Company Summary
7.9.2 Arrowhead Pharmaceuticals Business Overview
7.9.3 Arrowhead Pharmaceuticals Vector-Based RNAi Major Product Offerings
7.9.4 Arrowhead Pharmaceuticals Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.9.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.10 Arcturus Therapeutics
7.10.1 Arcturus Therapeutics Company Summary
7.10.2 Arcturus Therapeutics Business Overview
7.10.3 Arcturus Therapeutics Vector-Based RNAi Major Product Offerings
7.10.4 Arcturus Therapeutics Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.10.5 Arcturus Therapeutics Key News & Latest Developments
7.11 Alnylam Pharmaceuticals
7.11.1 Alnylam Pharmaceuticals Company Summary
7.11.2 Alnylam Pharmaceuticals Vector-Based RNAi Business Overview
7.11.3 Alnylam Pharmaceuticals Vector-Based RNAi Major Product Offerings
7.11.4 Alnylam Pharmaceuticals Vector-Based RNAi Sales and Revenue in Global (2018-2023)
7.11.5 Alnylam Pharmaceuticals Key News & Latest Developments
8 Global Vector-Based RNAi Production Capacity, Analysis
8.1 Global Vector-Based RNAi Production Capacity, 2018-2029
8.2 Vector-Based RNAi Production Capacity of Key Manufacturers in Global Market
8.3 Global Vector-Based RNAi Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vector-Based RNAi Supply Chain Analysis
10.1 Vector-Based RNAi Industry Value Chain
10.2 Vector-Based RNAi Upstream Market
10.3 Vector-Based RNAi Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vector-Based RNAi Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Vector-Based RNAi in Global Market
Table 2. Top Vector-Based RNAi Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Vector-Based RNAi Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Vector-Based RNAi Revenue Share by Companies, 2018-2023
Table 5. Global Vector-Based RNAi Sales by Companies, (K Units), 2018-2023
Table 6. Global Vector-Based RNAi Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Vector-Based RNAi Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Vector-Based RNAi Product Type
Table 9. List of Global Tier 1 Vector-Based RNAi Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vector-Based RNAi Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Vector-Based RNAi Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Vector-Based RNAi Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Vector-Based RNAi Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Vector-Based RNAi Sales (K Units), 2018-2023
Table 15. By Type - Global Vector-Based RNAi Sales (K Units), 2024-2029
Table 16. By Application – Global Vector-Based RNAi Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Vector-Based RNAi Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Vector-Based RNAi Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Vector-Based RNAi Sales (K Units), 2018-2023
Table 20. By Application - Global Vector-Based RNAi Sales (K Units), 2024-2029
Table 21. By Region – Global Vector-Based RNAi Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Vector-Based RNAi Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Vector-Based RNAi Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Vector-Based RNAi Sales (K Units), 2018-2023
Table 25. By Region - Global Vector-Based RNAi Sales (K Units), 2024-2029
Table 26. By Country - North America Vector-Based RNAi Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Vector-Based RNAi Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Vector-Based RNAi Sales, (K Units), 2018-2023
Table 29. By Country - North America Vector-Based RNAi Sales, (K Units), 2024-2029
Table 30. By Country - Europe Vector-Based RNAi Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Vector-Based RNAi Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Vector-Based RNAi Sales, (K Units), 2018-2023
Table 33. By Country - Europe Vector-Based RNAi Sales, (K Units), 2024-2029
Table 34. By Region - Asia Vector-Based RNAi Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Vector-Based RNAi Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Vector-Based RNAi Sales, (K Units), 2018-2023
Table 37. By Region - Asia Vector-Based RNAi Sales, (K Units), 2024-2029
Table 38. By Country - South America Vector-Based RNAi Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Vector-Based RNAi Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Vector-Based RNAi Sales, (K Units), 2018-2023
Table 41. By Country - South America Vector-Based RNAi Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Vector-Based RNAi Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Vector-Based RNAi Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Vector-Based RNAi Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Vector-Based RNAi Sales, (K Units), 2024-2029
Table 46. Merck & Co. Company Summary
Table 47. Merck & Co. Vector-Based RNAi Product Offerings
Table 48. Merck & Co. Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck & Co. Key News & Latest Developments
Table 50. Phio Pharmaceutical Company Summary
Table 51. Phio Pharmaceutical Vector-Based RNAi Product Offerings
Table 52. Phio Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Phio Pharmaceutical Key News & Latest Developments
Table 54. Quark Pharmaceuticals Company Summary
Table 55. Quark Pharmaceuticals Vector-Based RNAi Product Offerings
Table 56. Quark Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Quark Pharmaceuticals Key News & Latest Developments
Table 58. Thermo Fisher Scientific Company Summary
Table 59. Thermo Fisher Scientific Vector-Based RNAi Product Offerings
Table 60. Thermo Fisher Scientific Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Thermo Fisher Scientific Key News & Latest Developments
Table 62. Silence Therapeutics Company Summary
Table 63. Silence Therapeutics Vector-Based RNAi Product Offerings
Table 64. Silence Therapeutics Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Silence Therapeutics Key News & Latest Developments
Table 66. Qiagen NV Company Summary
Table 67. Qiagen NV Vector-Based RNAi Product Offerings
Table 68. Qiagen NV Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Qiagen NV Key News & Latest Developments
Table 70. Ionis Pharmaceutical Company Summary
Table 71. Ionis Pharmaceutical Vector-Based RNAi Product Offerings
Table 72. Ionis Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Ionis Pharmaceutical Key News & Latest Developments
Table 74. Dicerna Pharmaceuticals Company Summary
Table 75. Dicerna Pharmaceuticals Vector-Based RNAi Product Offerings
Table 76. Dicerna Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Dicerna Pharmaceuticals Key News & Latest Developments
Table 78. Arrowhead Pharmaceuticals Company Summary
Table 79. Arrowhead Pharmaceuticals Vector-Based RNAi Product Offerings
Table 80. Arrowhead Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Arrowhead Pharmaceuticals Key News & Latest Developments
Table 82. Arcturus Therapeutics Company Summary
Table 83. Arcturus Therapeutics Vector-Based RNAi Product Offerings
Table 84. Arcturus Therapeutics Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Arcturus Therapeutics Key News & Latest Developments
Table 86. Alnylam Pharmaceuticals Company Summary
Table 87. Alnylam Pharmaceuticals Vector-Based RNAi Product Offerings
Table 88. Alnylam Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Alnylam Pharmaceuticals Key News & Latest Developments
Table 90. Vector-Based RNAi Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Vector-Based RNAi Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Vector-Based RNAi Production by Region, 2018-2023 (K Units)
Table 93. Global Vector-Based RNAi Production by Region, 2024-2029 (K Units)
Table 94. Vector-Based RNAi Market Opportunities & Trends in Global Market
Table 95. Vector-Based RNAi Market Drivers in Global Market
Table 96. Vector-Based RNAi Market Restraints in Global Market
Table 97. Vector-Based RNAi Raw Materials
Table 98. Vector-Based RNAi Raw Materials Suppliers in Global Market
Table 99. Typical Vector-Based RNAi Downstream
Table 100. Vector-Based RNAi Downstream Clients in Global Market
Table 101. Vector-Based RNAi Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vector-Based RNAi Segment by Type in 2022
Figure 2. Vector-Based RNAi Segment by Application in 2022
Figure 3. Global Vector-Based RNAi Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vector-Based RNAi Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Vector-Based RNAi Revenue, 2018-2029 (US$, Mn)
Figure 7. Vector-Based RNAi Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Vector-Based RNAi Revenue in 2022
Figure 9. By Type - Global Vector-Based RNAi Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 11. By Type - Global Vector-Based RNAi Sales Market Share, 2018-2029
Figure 12. By Type - Global Vector-Based RNAi Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Vector-Based RNAi Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 15. By Application - Global Vector-Based RNAi Sales Market Share, 2018-2029
Figure 16. By Application - Global Vector-Based RNAi Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Vector-Based RNAi Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Vector-Based RNAi Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 20. By Region - Global Vector-Based RNAi Sales Market Share, 2018-2029
Figure 21. By Country - North America Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 22. By Country - North America Vector-Based RNAi Sales Market Share, 2018-2029
Figure 23. US Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Vector-Based RNAi Sales Market Share, 2018-2029
Figure 28. Germany Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 29. France Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Vector-Based RNAi Sales Market Share, 2018-2029
Figure 37. China Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 41. India Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 43. By Country - South America Vector-Based RNAi Sales Market Share, 2018-2029
Figure 44. Brazil Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Vector-Based RNAi Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Vector-Based RNAi Sales Market Share, 2018-2029
Figure 48. Turkey Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Vector-Based RNAi Revenue, (US$, Mn), 2018-2029
Figure 52. Global Vector-Based RNAi Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Vector-Based RNAi by Region, 2022 VS 2029
Figure 54. Vector-Based RNAi Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のベクターベースRNAi市場予測2023-2029：siRNA設計、siRNAベクター、カスタムsiRNA構築] (コード：MMG23LY8740)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のベクターベースRNAi市場予測2023-2029：siRNA設計、siRNAベクター、カスタムsiRNA構築]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のCAR T細胞型薬剤市場予測2023-2029：CD19標的、BCMA標的
  • 世界のTCR抗体市場予測2023-2029：NY-ESO-1、p53、WT-1、EBv、その他
  • 世界の季節性アレルギー性鼻炎薬市場予測2023-2029：GSP-301、PF-06444753、VTX-1463、その他
  • 世界のタンパク質及びペプチド治療薬市場予測2023-2029：注射式、経口式
  • 世界の腎代替療法市場予測2023-2029：デバイス、消耗品、サービス

    • ◆H&Iグローバルリサーチのお客様（例）◆